Is the era of mega-mergers over? IQVIA Pharma Deals data reveals a 53% decrease in mean M&A deal value for Q4 2024. Only 7 deals exceeded $1B, compared to 13 in Q4 2023. Learn how this trend could create new opportunities for strategic growth. Read the article to get the full analysis today! https://bit.ly/3Dlxkyk #PharmaDeals #BiopharmaStrategy #MergersAndAcquisitions
关于我们
Through our Gold Standard data and analytics, Global Market Insights supports pharmaceutical and life sciences organizations in measuring, managing and segmenting markets, finding and sizing opportunities and maximizing the return on investment across the pharmaceutical drug lifecycle worldwide.
- 网站
-
https://www.iqvia.com
IQVIA Global Market Insights的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Durham，North Carolina
动态
-
Ready to revolutionize your business strategy? Introducing IQVIA Market Prognosis with AI Assistant! Combine industry-leading 5-year forecasts spanning 49 countries with cutting-edge AI for unparalleled forecasts and insights at unprecedented speed. Elevate your decision-making! Learn more https://bit.ly/4iofV6G #MarketPrognosisAI #AIAssistant #PharmaAI?
-
-
Launching a new product this year? Learn from the wins (and losses) of last year’s pharma launches. Join us for the webinar IQVIA Early Bird: Pharma Defining Trends in 2024 and What Lies Ahead. We're also providing you with the first view of the complete metrics for 2024, highlighting fast changing market dynamics coupled with new launches and rapid growth in novel modalities to help you nail your next launch. Secure your spot: https://bit.ly/4iolx0Q #IQVIAMIDAS #MIDASPatient #ChannelDynamicsVerbatim #MarketPrognosis #AIAssistant
-
-
Check out the latest #INNsightNewsletter! This month, we explore the decline in #MandA deals in late 2024 and assess the #BiosimilarVoid in the U.S. Plus, we're provide an outlook for obesity in 2025, which promises to be more than just a transition year. If you have already, make sure to register for our upcoming webinar, "IQVIA Early Bird - Pharma Defining Trends in 2024 and What Lies Ahead," where we'll be giving you an exclusive preview of the pharma market's 2024's growth and key insights to help you stay ahead in 2025. Don't miss it! Click through to read more and subscribe for future updates! #PharmaDeals #ForecastLink #AnalyticsLink #ArkPatentIntelligence
-
Meet IQVIA’s trailblazers reshaping pharma forecasting!?We are set to unveil a solution shortly that combines our unrivalled gold standard industry forecasts and expertise, with cutting-edge AI to process vast amounts of data and provide you with actionable insights in seconds. The future of pharmaceutical intelligence is almost here! Angela Gregory, Farhana Begum, Geetika Munjal, Sana Kauser, Jasmine Kalsi, Andrea Streit, Shreya Saxena, Nancy Malik, Monica G., Gagandeep Singh, Caterina Perrone - CAMS/CGSS, MSc, Yussuf I., Eduardo Magro, Swetha Saikumar, Shweta Malik, Divya Bharathi Nageswara, Ayushi S., Vismay Raje, Shivani Singh, Muskan Negi, Natasha Piper, Bhanu Prakash Chinna, Manasmita Murmu, Niharika Mishra Dr Abhishek Jaiswal #AIAssistant #AIinHealthcare #FutureOfHealthcare
-
As we reach the last day of February, let's remember that this month is National Cancer Prevention Month, a time to focus on the importance of proactive measures to reduce cancer risk. Simple lifestyle changes, regular screenings, and increased awareness can significantly contribute to cancer prevention. We are also incredibly thankful for the advancements in cancer treatment. mRNA technology is emerging as a promising option, offering fewer side effects and better quality of life for patients, especially those resistant to conventional therapies. You can learn more about this in this article https://bit.ly/3F01jMA #NationalCancerPreventionMonth #CancerPrevention #CancerAwareness #PipelineLink #TrialLink
-
-
Here's the latest insights into the biosimilar market by the IQVIA Institute for Human Data Science. This report dives deep into the challenges and opportunities within the #biosimilar market, characterizing the biosimilar void and offering practical solutions to maximize opportunities. #ArkPatentIntelligence #ForecastLink
The U.S. biosimilar market is at a crossroads. While biosimilars have already generated billions in savings, long-term sustainability is not guaranteed. Exhibit 13 from our latest report highlights key challenges threatening biosimilar adoption, including: ?? Regulatory hurdles that delay approval and raise costs ?? Market uncertainty slowing biosimilar adoption ?? High investment costs limiting manufacturer entry ?? Interchangeability confusion affecting provider and payer trust ?? Reimbursement and policy challenges impacting access If all biologics losing patent protection in the next 10 years had biosimilar alternatives at expiry, the U.S. healthcare system could see an additional $189Bn in savings. Check out the details in our latest report: https://bit.ly/3WXfCI5 #Biosimilars #DrugPricing #Pharma #HealthcarePolicy
-
-
Join us for IQVIA Early Bird: Pharma Defining Trends in 2024 and What Lies Ahead webinar on March 18. We're giving you an exclusive look at the first view of key pharma metrics for 2024, and we’ll unpack the trends in #oncology, #immunology, #obesity, and #biosimilars that are shaping our industry's future so you can plan ahead. Sign up now: https://bit.ly/4k9slBn #IQVIAMIDAS #MIDASPatient #ChannelDynamicsVerbatim #MarketPrognosis #AIAssistant
-
CNS and neuromuscular deals are heating up! IQVIA Pharma Deals data shows these indications commanded top dollar in Q4 2024. Discover why investors are bullish on brain health and see how this trend could reshape the pharma landscape. Download our article to learn more https://bit.ly/4bc9lhz #PharmaDeals #CNS #NeuroscienceInnovation
-
-
IQVIA Global Market Insights转发了
“We are thrilled to have won an Innovation Award from PM360 for IQVIA AI Assistant. This is recognition of how IQVIA AI Assistant is transforming the way healthcare and life sciences customers obtain critical insights.” - Bhavik Patel, President of Commercial Solutions, IQVIA. IQVIA AI Assistant, a conversational, generative AI-based interface, revolutionizes insight generation by providing rapid, relevant, and precise answers to complex business questions in moments. Read the full press release here: https://bit.ly/3ETAqda
-